MENU
+Compare
XFOR
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$3.29
Change
+$0.05 (+1.54%)
Capitalization
19.04M

XFOR X4 Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system... Show more

Industry: #Biotechnology
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XFOR with price predictions
May 08, 2025

XFOR's Indicator enters downward trend

The Aroon Indicator for XFOR entered a downward trend on May 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 291 similar instances where the Aroon Indicator formed such a pattern. In of the 291 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for XFOR turned negative on May 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XFOR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XFOR advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

XFOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.812) is normal, around the industry mean (14.243). P/E Ratio (1.526) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.693) is also within normal values, averaging (253.449).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XFOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XFOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XFOR is expected to report earnings to fall 320.75% to -8 cents per share on July 31

X4 Pharmaceuticals Inc XFOR Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.16
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.46
The last earnings report on May 01 showed earnings per share of 3 cents, beating the estimate of -11 cents. With 163.43K shares outstanding, the current market capitalization sits at 19.04M.
A.I. Advisor
published General Information

General Information

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
61 North Beacon Street
Phone
+1 857 529-8300
Employees
93
Web
https://www.x4pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOGP1.270.08
+7.05%
Sound Group
VRA1.960.08
+4.26%
Vera Bradley
CNS79.962.28
+2.94%
Cohen & Steers
FWRG15.99N/A
N/A
First Watch Restaurant Group
IRM96.74-0.18
-0.19%
Iron Mountain

XFOR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with XCUR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then XCUR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
+1.54%
XCUR - XFOR
34%
Loosely correlated
+14.14%
SPHDF - XFOR
34%
Loosely correlated
N/A
CRDF - XFOR
32%
Poorly correlated
+5.62%
ABSI - XFOR
31%
Poorly correlated
+5.26%
IMNM - XFOR
29%
Poorly correlated
+3.77%
More